PHARMACOKINETICS AND TOXICITY OF 2ND LINE ANTI-TB DRUGS IN HIV-INFECTED CHILDREN

Pascale Willem

The Coding Genome Of HIV-Associated Plasmablastic Lymphomas In South Africa

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Leona W Ayers

Mid-Region Aids and Cancer Specimen Resource Consortium

Hodgkin lymphoma Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Ronald T Mitsuyasu

AIDS Malignancy Clinical Trials Consortium (AMC)

Trachea, bronchus and lung Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Kaposi sarcoma Hodgkin lymphoma Colorectum Cervix uteri

Eric M Wohlford

The interaction of Burkitt's lymphoma Cofactors EBV and Plasmodium

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology Pediatric oncology or childhood cancer

Pamela Hoodless

Epigenetic Modifications Regulating Hepatocellular Carcinoma and Hepatocyte Differentiation

Liver and intrahepatic bile ducts

David L Woodland

Immune Evolution in Cancer

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Kenneth Lynn Wright

Natural Killer Cell Regulation by PRDM1 and IRF4/8

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Edward Seto

Targeting SIRT1 in Mantle Cell Lymphoma

Non-Hodgkin lymphoma Hodgkin lymphoma

Joseph H Antin

A Randomized Trial of Tac/MTX/bortezomib vs Tac/MTXplacebo in Allogeneic HSCT

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma